MyFinsight
Home
About
Contact
tlsi: the income statement
Download
Download image
Net loss
attributable to common...
-$41,274K
(-1189.01%↓ Y/Y)
Deemed dividend
related to seriesa...
$11,947K
Series a preferred
stock conversion...
$18,516K
Net loss
-$10,811K
(-350.65%↓ Y/Y)
Income tax benefit
(expense)
$5K
(266.67%↑ Y/Y)
Loss before income
taxes
-$10,806K
(-349.88%↓ Y/Y)
Change in fair value of
contingent earnout...
-$2,524K
(-6.95%↓ Y/Y)
Interest income
$170K
(7.59%↑ Y/Y)
Revenue
$11,566K
(57.38%↑ Y/Y)
Other expense, net
-$94K
(-623.08%↓ Y/Y)
Change in fair value of
sepa, warrant and...
-$2,932K
(-158.95%↓ Y/Y)
Interest expense
$1,460K
(27.85%↑ Y/Y)
Loss from operations
-$9,014K
(-3.15%↓ Y/Y)
Gross profit
$9,660K
(52.25%↑ Y/Y)
Cost of goods sold
$1,906K
(89.84%↑ Y/Y)
General and
administrative
$6,659K
(40.87%↑ Y/Y)
Sales and marketing
$6,839K
(11.42%↑ Y/Y)
Research and development
$5,176K
(22.68%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. (TLSI)